From: Exosome-based strategies for diagnosis and therapy of glioma cancer
Exosomal microRNA | Sample | Target | Note (result) | Expression status | Refs. |
---|---|---|---|---|---|
miR-301a | Serum of glioma patients | TCEAL7 | Migration of β-catenin from cytoplasm to the nucleus was impeded by TCEAL7 which resulted in regulation of Wnt/β-catenin pathway and so TCEAL7 could be tumor suppressor in GMB | up | [67] |
miR-151a | GBM patients | XRCC4 | Decreasing the amount of XRCC4, postponing the clearance of DSB and increase the sensitivity of cells to TMZ was induced by miR-151a | up | [68] |
miR-1238 | Human tissue samples (GBM specimens) | CAV1 | Absence of miR-1238 can increase sensitivity of resistant GBM cells through CAV1/EGFR pathway | up | [71] |
mir-5096 | Human microvascular endothelial cells (HMEC) & Glioblastoma cells U87-U251 | Kir4.1, AQP-4 | In gliomas, miR-5096 was found to be downregulated | down | [73] |
miR-148a | Human glioblastoma cell line T98G | CADM1 | STAT3 signaling pathway was activated by miR-148a through targeting CADM1 and stimulates proliferation and metastasis | down | [77] |
miR-29a | 10-week-old male C57BL/6 mice/ Myeloid-derived suppressor cells (MDSCs) | Hbp1 | In gliomas, miR-29a expression was increased | up | [78] |
miR-92a | 10-week-old male C57BL/6 mice/ Myeloid-derived suppressor cells (MDSCs) | Prkar1a | Up regulations of miR-92a was seen in gliomas | up | [78] |
miR-133b | Human brain tissues (Normal & glioma) | EZH2 | EZH2 and the Wnt/β-catenin signaling pathway inhibiting by miR-133b which lead to suppression of proliferation, invasion, and migration | down | [201] |
miR-199a | Human brain tissues (Normal & glioma) | AGAP2 | miR-199a decreased expression of AGAP2which lead to suppressing of glioma development | down | [202] |
miRNA-584-5p | U87 human glioma cells | CYP2J2 | miRNA-584-5p lessen the growth and intrusion of glioma cells | up | [203] |
miR-9 | Glioma patient specimens & glioma cell lines | COL18A1, THBS2, PTCH1 and PHD3 | angiogenesis was elevated by miR-9 | up | [204] |
miR-10a and miR-21 | glioma patients | RORA, PTEN | expression of miR-10a and miR-21 stimulated by hypoxia in GDEs facilitates MDSC growth and activation via targeting RAR-related orphan receptor alpha (RORA) and phosphatase and tensin homolog (PETN) | up | [205] |
miR-21, miR-222 and miR-124-3p | Blood samples of glioma patients | – | Expression of miR-21, miR-222 and miR-124-3p were decreased in gliomas | up | [206] |
miR-125b | Tumor samples of GBM patients | – | Regulation of miR-125b increased in gliomas | up | [207] |
mir-21 | Human brain endothelial cells | VEGF | in gliomas expression of mir-21 increased | up | [66] |
miR-124a | Bone marrow–derived mesenchymal stem cells | FOXA2 | unusual lipid build-up inside cells due to silencing of FOXA2 by miR-124a | up | [208] |
miR-451, miR-21 | primary human glioblastoma | c-Myc | - | up | |
miR-221 | Human umbilical vein endothelial cells (HUVECs) | – | miR-221 expression in gliomas elevated | up | [211] |
miR-21, miR-103, miR-24, and miR-125 | serum and cerebrospinal fluid of glioblastoma patients | – | Expression of miR-21, miR-103, miR-24, and miR-125 in gliomas were increased | up | [212] |
miR-302–367 | GSCs primary cell lines TG1, TG6 and GB1 | CXCR4/SDF1, SHH, cyclin D, cyclin A and E2F1 | Cells which are adjusted to GBM internalized exosomes with high levels of miR-302–367 | up | [213] |
miR-1290, miR-1246 | patient-derived primary cells | – | Expression of miR-1290 and miR-1246 in gliomas increased | up | [214] |
miR-1587 | glioma-associated human mesenchymal stem cells (GA-hMSC) & glioma stem-like cells | NCOR1 | Expression of nuclear receptor co-repressor NCOR1which is tumor suppressor reduced by miR-1587 | down | [215] |
miR-375 | human marrow stromal cells (hMSCs) | SLC31A1 | While apoptosis promoted, immigration and intrusion and proliferation are inhibited by miR-375and suppression of SLC31A1development of glioma cell impeded | down | [216] |
miR-1246 | CSF of GBM patients | TERF2IP | The STAT3 signaling pathway is activated by miR-1246, while the NF-B signaling pathway is inhibited | down | [217] |
miR-124 | GBM patients | CDK6 | GBM cell movement is reduced by miR-124 | down | [218] |
miR-328-3p, miR-339-5p, miR-340-5p, miR-485and miR-543 -3p | serum specimens of patients with glioma tumors | – | Expression of miR-328-3p, miR-339-5p, miR-340-5p, miR-485-3p, and miR-543 were increased in glioma | up | [13] |
miR-182-5p, miR-486-5p | serum specimens of patients with glioma tumors | – | down | [13] | |
miR-454-3p | serum and tissue samples of glioma patients | ATG12 | Immigration, intrusion and autophagy are inhibited in glioma by miR-454-3p | down | [219] |
miR-146b | rat model of primary brain tumor | EGFR and NF-κB | EGFR and NF-κB protein are reduced by miR-146b in 9 L glioma cells in vitro | down | [220] |
miR-301a | GBM patients | PTEN | expression of PTEN increased by miR-301a | up | [86] |
miR-221 | glioma patients | DNM3 | expression of DNM3 increased by miR-221 | up | [221] |
miR-26a | tissue samples of glioma patients | PTEN | Proliferation and angiogenesis are boosted by miR-26a | up | [222] |